$ cat ./records/gates-foundation-launches-reinvent-the-toilet-challenge-with-over-2011.txt
Gates Foundation Launches Reinvent the Toilet Challenge with Over $200 Million Commitment
[RECORD.TXT] · cat --full
In July 2011, the Gates Foundation launched the Reinvent the Toilet Challenge, committing over $200 million across a decade to fund off-grid, waterless, pathogen-eliminating sanitation technologies at universities including Caltech, Duke, and institutions in China. At the 2018 Reinvented Toilet Expo in Beijing, Bill Gates unveiled prototype waterless toilets and pledged an additional $200 million to support market development. The initiative targets the 2.5 billion people worldwide lacking safe sanitation and the 1,000 children under five who die daily from diseases caused by poor sanitation.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Awards $8.3 Million to Danforth Plant Science Center for BioCassava Plus Vitamin-Fortified Cassava
Next →
ROTAVAC — Gates-Supported $1 Oral Rotavirus Vaccine Reaches 25 Million Indian Children Annually
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.